Reference ID: 3675798 - Food and Drug Administration

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID.

ZEGERID (omeprazole/sodium bicarbonate) powder for oral suspension ZEGERID (omeprazole/sodium bicarbonate) capsules for oral use Initial U.S. Approval: 2004

--------?----------RECENT MAJOR CHANGES----------------?

Warnings and Precautions, Acute Interstitial Nephritis (5.3)

12/2014

Warnings and Precautions, Cyanocobalamin

(Vitamin B-12) Deficiency (5.4)

12/2014

----------------------------INDICATIONS AND USAGE--------------------------ZEGERID is a proton pump inhibitor indicated for: ? Short-term treatment of active duodenal ulcer (1.1) ? Short-term treatment of active benign gastric ulcer (1.2) ? Treatment of gastroesophageal reflux disease (GERD) (1.3) ? Maintenance of healing of erosive esophagitis (1.4) ? Reduction of risk of upper GI bleeding in critically ill patients (1.5)

The safety and effectiveness of ZEGERID in pediatric patients ( ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download